| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | 0.035 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.0065 | 0.8 |
| mRNA | EX-527 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | 0.0068 | 0.8 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0065 | 0.8 |